Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose and water preload for postprandial hypotension
ACTRN12618000152224Phase 4Completed
- Sponsor
- Professor Karen Jones
- Start
- Jan 2011
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of acarbose in Postprandial hypotension (PPH) (4 arms), sponsored by Professor Karen Jones. Primary endpoint: Change in blood pressure. Started Jan 2011; status: completed.
02
Drugs
acarbose
03
Conditions
Postprandial hypotension (PPH)
Beyond the preview
Go deeper on ACTRN12618000152224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000152224.